Stocks to Watch: Applovin, Disney, Galera Therapeutics
10 8월 2023 - 9:10AM
Dow Jones News
By Ben Glickman
AppLovin reported a better-than-expected profit in the second
quarter as the company's sales rose. The software company posted
net income of $80.36 million, or 22 cents a share, while analysts
polled by FactSet expected earnings of 8 cents a share. Shares
climbed 24% to $36.48 in after-hours trading.
Walt Disney said it would significantly raise prices for its
Disney+ and Hulu streaming services as it looks to make its
direct-to-consumer business profitable. The streaming segment's
loss narrowed in the second quarter, posting a loss of $512 million
compared with $1.06 billion a year earlier. Disney shares rose 2.7%
to $89.87 in after-hours trading.
Galera Therapeutics said the Food and Drug Administration told
the company that results for one of its drug candidates weren't
enough to warrant approval. The company said it would reduce its
workforce by 70% in order to extend its cash runway following the
FDA's decision. Shares fell 82% to 41 cents in after-hours
trading.
Write to Ben Glickman at ben.glickman@wsj.com
(END) Dow Jones Newswires
August 09, 2023 19:55 ET (23:55 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Galera Therapeutics (NASDAQ:GRTX)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
Galera Therapeutics (NASDAQ:GRTX)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024